Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David Sebinger"'
Autor:
Matthew McDonald, David Sebinger, Lisa Brauns, Laura Gonzalez-Cano, Yotam Menuchin-Lasowski, Michael Mierzejewski, Olympia-Ekaterini Psathaki, Angelika Stumpf, Jenny Wickham, Thomas Rauen, Hans Schöler, Peter D. Jones
Publikováno v:
Biosensors and Bioelectronics. 228:115223
Autor:
Angela Schulz, Heike Biebermann, Philipp Mergenthaler, Heiko Krude, Peter Kühnen, Ingo Bechmann, Peter Vajkoczy, Harald Stachelscheid, Sarah Paisdzior, Robert Opitz, Bianca Mages, Nina-Maria Wilpert, Eva K. Wirth, Joachim Spranger, Martin Krueger, David Sebinger
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 30(9)
Background: Mutations of monocarboxylate transporter 8 (MCT8), a thyroid hormone (TH)-specific transmembrane transporter, cause a severe neurodevelopmental disorder, the Allan-Herndon-Dudley syndrome. In MCT8 deficiency, TH is not able to reach those
Publikováno v:
Mutation Research/Reviews in Mutation Research. 488:211-231
Cell death by apoptosis is exerted by the coordinated action of many different gene products. Mutations in some of them, acting at different levels in the apoptosis process, have been identified as cause or contributing factor for human diseases. Def
Autor:
Markus Hengstschläger, Andreas Chott, Leonhard Müllauer, David Sebinger, Petra Gruber, Markus Raderer, Sabine Wohlfart, Doris Polgar, Georg Krupitza, Margit Rosner, Judith Buch
A loss of FAS (CD95) function has been proposed to constitute an important step in early mucosa-associated lymphoid tissue (MALT) lymphoma development and FAS mutations have been recognized in malignant lymphomas, in particular at extranodal sites. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c748dbfdeef1b8c8541158752723f982
https://europepmc.org/articles/PMC1614721/
https://europepmc.org/articles/PMC1614721/